Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
- Sprache
-
Englisch
- Identifier
-
1229997954
Beteiligte Personen und Organisationen
- DOI
-
10.18154/RWTH-CONV-236134
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:52 MEZ
Beteiligte
- Weiskirchen, Ralf
- Weiskirchen, Sabine
- Tacke, Frank
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Die Rolle von CCR2+ Makrophagen für die Angiogenese und Tumorvaskularisation in fibrotisch veränderten Lebern
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Mechanisms of liver fibrosis resolution
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Relevance of serum leptin and leptin-receptor concentrations in critically ill patients
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Die Rolle von CCR2+ Makrophagen für die Angiogenese und Tumorvaskularisation in fibrotisch veränderten Lebern
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Mechanisms of liver fibrosis resolution
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Relevance of serum leptin and leptin-receptor concentrations in critically ill patients
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
Die Rolle von CCR2+ Makrophagen für die Angiogenese und Tumorvaskularisation in fibrotisch veränderten Lebern
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
Mechanisms of liver fibrosis resolution
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Relevance of serum leptin and leptin-receptor concentrations in critically ill patients
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis